In summary, our experiments revealed that by regulating the composition of GM, such as Akkermansia, SYD might interact with the IL‐17/TNF/NF‐κB signaling axis, enhancing intestinal immunity, metabolic pathways, and inflammatory responses to influence the development and progression of CRC. The gene discussed is NFKB1; the disease is colorectal carcinoma.